193 related articles for article (PubMed ID: 17414316)
1. The new B7s: playing a pivotal role in tumor immunity.
Flies DB; Chen L
J Immunother; 2007 Apr; 30(3):251-60. PubMed ID: 17414316
[TBL] [Abstract][Full Text] [Related]
2. Targeting costimulatory pathways for tumor immunotherapy.
Ward RC; Kaufman HL
Int Rev Immunol; 2007; 26(3-4):161-96. PubMed ID: 17558743
[TBL] [Abstract][Full Text] [Related]
3. Modulation of immune response by B7 family molecules in tumor microenvironments.
Flies DB; Chen L
Immunol Invest; 2006; 35(3-4):395-418. PubMed ID: 16916759
[TBL] [Abstract][Full Text] [Related]
4. Teleost B7 expressed on monocytes regulates T cell responses.
Sugamata R; Suetake H; Kikuchi K; Suzuki Y
J Immunol; 2009 Jun; 182(11):6799-806. PubMed ID: 19454675
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory B7-family molecules in the tumour microenvironment.
Zou W; Chen L
Nat Rev Immunol; 2008 Jun; 8(6):467-77. PubMed ID: 18500231
[TBL] [Abstract][Full Text] [Related]
6. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
7. The B7 family of immunoregulatory receptors: a comparative and evolutionary perspective.
Hansen JD; Du Pasquier L; Lefranc MP; Lopez V; Benmansour A; Boudinot P
Mol Immunol; 2009 Jan; 46(3):457-72. PubMed ID: 19081138
[TBL] [Abstract][Full Text] [Related]
8. Dormant tumor cells as a therapeutic target?
Quesnel B
Cancer Lett; 2008 Aug; 267(1):10-7. PubMed ID: 18384938
[TBL] [Abstract][Full Text] [Related]
9. 12-O-tetradecanoyl phorbol 13-acetate induces the expression of B7-DC, -H1, -H2, and -H3 in K562 cells.
Jang BC; Park YK; Choi IH; Kim SP; Hwang JB; Baek WK; Suh MH; Mun KC; Suh SI
Int J Oncol; 2007 Dec; 31(6):1439-47. PubMed ID: 17982670
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer.
Loos M; Giese NA; Kleeff J; Giese T; Gaida MM; Bergmann F; Laschinger M; W Büchler M; Friess H
Cancer Lett; 2008 Sep; 268(1):98-109. PubMed ID: 18486325
[TBL] [Abstract][Full Text] [Related]
11. The B7 family and cancer therapy: costimulation and coinhibition.
Zang X; Allison JP
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5271-9. PubMed ID: 17875755
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease.
Oikawa T; Takahashi H; Ishikawa T; Hokari A; Otsuki N; Azuma M; Zeniya M; Tajiri H
Pathol Int; 2007 Aug; 57(8):485-92. PubMed ID: 17610472
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice.
Kim TS; Lee BC; Kim E; Cho D; Cohen EP
Vaccine; 2008 Nov; 26(47):5928-34. PubMed ID: 18793691
[TBL] [Abstract][Full Text] [Related]
14. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS; Quezada SA; Allison JP
Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
[TBL] [Abstract][Full Text] [Related]
15. B7-H4 reverse signaling induces the apoptosis of EBV-transformed B cells through Fas ligand up-regulation.
Song H; Park G; Kim YS; Hur I; Kim H; Ryu JW; Lee HK; Cho DH; Choi IH; Lee WJ; Hur DY
Cancer Lett; 2008 Aug; 266(2):227-37. PubMed ID: 18417276
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic opportunities in the B7/CD28 family of ligands and receptors.
Carreno BM; Carter LL; Collins M
Curr Opin Pharmacol; 2005 Aug; 5(4):424-30. PubMed ID: 15935730
[TBL] [Abstract][Full Text] [Related]
17. Induction of regulatory dendritic cells by topical application of NF-kappaB decoy oligodeoxynucleotides.
Isomura I; Shintani Y; Yasuda Y; Tsujimura K; Morita A
Immunol Lett; 2008 Aug; 119(1-2):49-56. PubMed ID: 18547648
[TBL] [Abstract][Full Text] [Related]
18. B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration.
Miyatake T; Tringler B; Liu W; Liu SH; Papkoff J; Enomoto T; Torkko KC; Dehn DL; Swisher A; Shroyer KR
Gynecol Oncol; 2007 Jul; 106(1):119-27. PubMed ID: 17509674
[TBL] [Abstract][Full Text] [Related]
19. Could B7-H4 serve as a target to activate anti-cancer immunity?
Wang L; Heng X; Lu Y; Cai Z; Yi Q; Che F
Int Immunopharmacol; 2016 Sep; 38():97-103. PubMed ID: 27258187
[TBL] [Abstract][Full Text] [Related]
20. Potential targeting of B7-H4 for the treatment of cancer.
Podojil JR; Miller SD
Immunol Rev; 2017 Mar; 276(1):40-51. PubMed ID: 28258701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
